JIVANA BIOTECHNOLOGY INC has a total of 17 patent applications. Its first patent ever was published in 2018. It filed its patents most often in Argentina, Taiwan and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and biotechnology are VLP BIOTECH INC, INTROGEN THERAPEUTICS INC and NABEL GARY J.
# | Country | Total Patents | |
---|---|---|---|
#1 | Argentina | 6 | |
#2 | Taiwan | 6 | |
#3 | WIPO (World Intellectual Property Organization) | 5 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Mathur Aditi | 17 |
#2 | Hopps Sidney | 17 |
#3 | Prabhakar Bellur | 17 |
#4 | Saini Shikha | 17 |
#5 | Yue Fei | 17 |
Publication | Filing date | Title |
---|---|---|
TW201902487A | Synergistic combination of nucleic acid oligonucleotides and protein kinase inhibitor chemotherapy | |
TW201902910A | Synergistic combination of nucleic acid oligonucleotides and apoptosis-inducing molecular therapeutics | |
TW201902489A | Synergistic combination of nucleic acid oligonucleotides and nucleoside analog chemotherapeutics | |
TW201900183A | Synergistic combination of nucleic acid oligonucleotides and alkylating agent chemotherapeutics | |
TW201902488A | Synergistic combination of nucleic acid oligonucleotides and taxane chemotherapeutics | |
TW201902912A | Synergistic combination of nucleic acid oligonucleotides and anthracycline chemotherapeutic agents |